12:30pm-2:00pm |
Lunch
Keynote Address
Tom Finneran, President
Massachusetts Biotechnology Council, Inc.
Panel
Burt Adelman, MD, Executive Vice President, Development
Biogen Idec, Inc.
Henry Kay, Group Vice President, New Market Development/Strategic Planning, Endosurgery,
Boston Scientific Corporation
Michael Kauffman, MD, PhD, President and CEO
Predix Pharmaceuticals Inc.
Richard A. Kramer, PhD
Strategic Alliance Manager, Functional Genomics
Novartis Institutes for BioMedical Research
Moderator
Robin JR Blatt
CJP Life Sciences Project
|
